The Newsroom
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Mayor Demings, AdventHealth on bridging health care gaps
Recent Stories at AdventHealthMD
-
-
Eighth-Generation Physician Blends Science and Art with Her Eastern Heritage to Provide Whole-Person Care
-
AdventHealth for Women Orlando First in Florida Named Level IV Maternal Care Verified Facility by The Joint Commission
-
AdventHealth physicians call their mission trip to help children with facial defects a labor of love
-
New Research Shows Having an Inflammatory Side Effect During Monoclonal Antibody Treatments for Lung Cancer is Linked to Improved Survival Rates
-
AI-powered imaging device tested in real-time as part of AdventHealth prostate cancer research study
-
AdventHealth physicians explain Post-COVID Clinic model and first year research findings during American Hospital Association podcast
-
Research and Teaching Are Our Future: AdventHealth Chief Clinical Officer Reflects on Three Decades of Leadership
-
AdventHealth research contributes to approval of first FDA-approved drug to delay onset of Type 1 diabetes